ĀÜĄņĀŅĀ×

Dr. Michelle White joined FidoCure in 2022 as the Head of Science. She is particularly driven by excitement and urgency to use precision medicine to help dogs and humans. Ultimately, Dr. White is most passionate about treating each patient as an individual, using emerging technologies and insights to improve the lives of the animals and people we love.

During her freshman year at Harvard University, Michelle became enamored with genetics. She was fortunate to be accepted into the lab of Daniel Hartl PhD., where she focused on the interface between evolutionary biology and genomics. After graduating from Harvard, she spent several years as an internal consultant and retail analyst for retail companies in New York City. Michelle was later accepted to Cornell where she received first her DVM and later, a PhD in Translational Medicine working in the lab of Adam Boyko.

In 2020, Michelle joined Dr. Elinor Karlssonā€™s laboratory as a Senior Research Scientist at the University of Massachusetts Chan Medical School and the Broad Institute of MIT and Harvard. During her tenure there she collaborated with two FidoCure scientific advisory board members, Dr. Cheryl London and Dr. Corrie Painter.

Originally from Ohio, Michelle spent most of her adult life in both New York state (including NYC as well as Ithaca). Her husband Adam is a small animal surgery resident at the University of Wisconsin. They reside in Madison with their son, two cats (Sophie Von Cat and Squirrel) and a dog named Merlin. She loves home automation, fermenting foods, and speaks mainly in references from The Simpsons.